4.6 Review

Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives

Related references

Note: Only part of the references are listed.
Article Oncology

ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma

Yuanbo Cui et al.

Summary: This study showed that LncRNA ESCCAL-1 promotes the tumorigenesis and cell-cycle progression of ESCC by interacting with and stabilizing the Gal-1 protein. ESCCAL-1 is up-regulated in ESCC tissues and has promising diagnostic value.

NPJ PRECISION ONCOLOGY (2022)

Article Engineering, Biomedical

Therapeutic potential of targeting galectins-A biomaterials-focused perspective

Sergio Martin-Saldana et al.

Summary: Galectins, a family of glycan-binding proteins, play a key role in immune cell homeostasis and modulation. Some members of the galectin family are crucial in the resolution of inflammation, while others perpetuate the immune response in a pathological context. They have the potential to be targeted for new therapies, and engineered biomaterials show promise in improving the therapeutic performance of galectin-targeted strategies.

BIOMATERIALS (2022)

Review Biochemistry & Molecular Biology

Galectokines: The Promiscuous Relationship between Galectins and Cytokines

Lucia Sanjurjo et al.

Summary: Galectins, a family of glycan-binding proteins, play a role in shaping the immune microenvironment by directly affecting immune cell activity and survival, as well as indirectly affecting immune response through binding to cytokines. Galectin-cytokine heterodimers, known as galectokines, add complexity to immune homeostasis regulation. This article summarizes current knowledge on galectokine formation and function, describes mechanisms by which galectokines shape the immune microenvironment, and discusses outstanding questions and challenges for future research on the role of galectokines in immunomodulation.

BIOMOLECULES (2022)

Article Oncology

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker

Tatsuki Nanami et al.

Summary: This study evaluated serum galectin-1 antibodies in different cancer types and found that patients with hepatocellular carcinoma and lung cancer had significantly higher positive rates, suggesting the potential utility of s-GAL-1-Abs in these specific cancer types.

MOLECULAR AND CLINICAL ONCOLOGY (2021)

Article Oncology

Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study

Ali Al-Kaabi et al.

Summary: This nationwide study in the Netherlands investigated the association between pathological tumor response and prognosis in esophageal cancer patients. It found that a quarter of patients achieved favorable long-term survival with complete pathological response, while one-third had very poor survival with incomplete response. These findings suggest the importance of considering pathological tumor response in assessing individual prognosis and treatment decisions.

ACTA ONCOLOGICA (2021)

Article Oncology

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies

Leonie K. de Klerk et al.

Summary: This study identified candidate genetic biomarkers associated with response to neoadjuvant chemoradiotherapy in patients with localized oesophageal cancer, involving multiple genes. Some markers were associated with favorable histopathological response and shorter survival, while others were correlated with unfavorable histopathological response and prolonged survival.

MOLECULAR ONCOLOGY (2021)

Article Multidisciplinary Sciences

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

Riyao Yang et al.

Summary: The study reveals that PD-1 contributes to exhausted T cell survival by binding to TIM-3 ligand Gal-9 and inhibiting Gal-9/TIM-3 induced cell death. Anti-Gal-9 therapy selectively expands intratumoral TIM-3(+) cytotoxic CD8 T cells and T-reg cells, while combination treatment with anti-Gal-9 and GITR agonist shows synergistic antitumor activity.

NATURE COMMUNICATIONS (2021)

Review Oncology

Expression and Impact of C1GalT1 in Cancer Development and Progression

Yangu Wan et al.

Summary: C1GalT1 is an important enzyme that is overexpressed in various common cancers, associated with poorer prognosis and patient survival. Changes in C1GalT1 expression lead to glycosylation alterations in many cell membrane glycoproteins, affecting cancer cell activity and behaviors.

CANCERS (2021)

Article Biology

Chemokines modulate glycan binding and the immunoregulatory activity of galectins

Lucia Sanjurjo et al.

Summary: The study reveals that specific chemokine-galectin interactions can modulate the immunoregulatory function of galectins, affecting their glycan-binding activity and specificity. In particular, binding of CXCL4 changes the carbohydrate binding site of galectin-1, increasing its apoptotic activity on CD8(+) T cells.

COMMUNICATIONS BIOLOGY (2021)

Article Medicine, General & Internal

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly et al.

Summary: In patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, adjuvant therapy with nivolumab significantly improved disease-free survival compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Molecular phenotyping reveals the identity of Barrett's esophagus and its malignant transition

Karol Nowicki-Osuch et al.

Summary: This study revealed that Barrett's esophagus originates from the gastric cardia through specific transcriptional programs. Esophageal adenocarcinoma likely arises from undifferentiated Barrett's esophagus cell types, even in the absence of a clearly identifiable metaplastic precursor. This finding has important implications for early cancer detection strategies.

SCIENCE (2021)

Article Oncology

Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma

Shau-Hsuan Li et al.

Summary: Galectin-1 has been found to be associated with poor outcomes in patients with locally advanced esophageal squamous cell carcinoma. Higher expression levels were significantly correlated with lower pathological complete response rates and worse overall survival. Therefore, galectin-1 may be a potential therapeutic target for patients receiving preoperative chemoradiotherapy.

CANCERS (2021)

Article Biochemistry & Molecular Biology

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma

Yu-Sen Lin et al.

Summary: Hypoxia and angiogenesis are key factors in the pathogenesis of esophageal squamous cell carcinoma (ESCC). This study reveals a novel function of ADAM9 in ESCC progression through transcriptional regulation of the angiogenesis pathway. ADAM9 acts as a transcriptional repressor in the nucleus, promoting tumor angiogenesis.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Oncology

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma

R. S. A. Goedegebuure et al.

Summary: In-depth analysis revealed a close relationship between the levels and distribution of T cells and the response to neoadjuvant CRT in esophageal adenocarcinoma patients. The presence of memory T cells in peripheral blood T cells contributes to a complete pathological response to CRT.

ONCOIMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Chemokines and galectins form heterodimers to modulate inflammation

Veit Eckardt et al.

EMBO REPORTS (2020)

Review Immunology

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression

Maria Romina Girotti et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Multidisciplinary Sciences

The Animal Lectin Galectin-8 Promotes Cytokine Expression and Metastatic Tumor Growth in Mice

Hadas Shatz-Azoulay et al.

SCIENTIFIC REPORTS (2020)

Article Biochemistry & Molecular Biology

Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model

Taiga Chiyo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Peripheral Vascular Disease

Different angioregulatory activity of monovalent galectin-9 isoforms

Ed Aanhane et al.

ANGIOGENESIS (2018)

Article Biochemistry & Molecular Biology

Adhesion/growth-regulatory galectins tested in combination: evidence for formation of hybrids as heterodimers

Michelle C. Miller et al.

BIOCHEMICAL JOURNAL (2018)

Review Biochemistry & Molecular Biology

Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives

Kamil Wdowiak et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Cell Biology

Galectins at a glance

Ludger Johannes et al.

JOURNAL OF CELL SCIENCE (2018)

Article Agriculture, Multidisciplinary

Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling

Wen Wen Xu et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Glycosylation: a hallmark of cancer?

Bhairavi N. Vajaria et al.

GLYCOCONJUGATE JOURNAL (2017)

Review Biochemistry & Molecular Biology

Translating the 'Sugar Code' into Immune and Vascular Signaling Programs

Juan P. Cerliani et al.

TRENDS IN BIOCHEMICAL SCIENCES (2017)

Article Medicine, General & Internal

Oesophageal cancer

Elizabeth C. Smyth et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Oncology

Cleavage and phosphorylation: important post-translational modifications of galectin-3

Xiaoge Gao et al.

CANCER AND METASTASIS REVIEWS (2017)

Article Multidisciplinary Sciences

Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering

Olga Blazevits et al.

SCIENTIFIC REPORTS (2016)

Review Biochemistry & Molecular Biology

Re-wiring regulatory cell networks in immunity by galectin-glycan interactions

Ada G. Blidner et al.

FEBS LETTERS (2015)

Article Oncology

Effect of galectin-3 on the behavior of Eca-109 human esophageal cancer cells

Ning Liang et al.

MOLECULAR MEDICINE REPORTS (2015)

Review Biochemistry & Molecular Biology

Vascular galectins: Regulators of tumor progression and targets for cancer therapy

Victor L. Thijssen et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2013)

Article Biochemistry & Molecular Biology

The Involvement of CD146 and Its Novel Ligand Galectin-1 in Apoptotic Regulation of Endothelial Cells

Nathalie Jouve et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Oncology

Altered galectin-1 serum levels in patients diagnosed with high-grade glioma

Tina Verschuere et al.

JOURNAL OF NEURO-ONCOLOGY (2013)

Article Multidisciplinary Sciences

Expression and Functions of Galectin-7 in Human and Murine Melanomas

Katherine Biron-Pain et al.

PLOS ONE (2013)

Article Biochemistry & Molecular Biology

Epigenetic Regulation of Galectin-3 Expression by β1 Integrins Promotes Cell Adhesion and Migration

Coert Margadant et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Medicine, General & Internal

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

P. van Hagen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Biochemistry & Molecular Biology

Modulation of endothelial cell migration and angiogenesis: a novel function for the tandem-repeat lectin galectin-8

Victor M. Cardenas Delgado et al.

FASEB JOURNAL (2011)

Article Oncology

Galectin-4 functions as a tumor suppressor of human colorectal cancer

Arun Satelli et al.

INTERNATIONAL JOURNAL OF CANCER (2011)

Review Biochemistry & Molecular Biology

Dynamics of galectin-3 in the nucleus and cytoplasm

Kevin C. Haudek et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)

Article Oncology

Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity

Victor L. Thijssen et al.

CANCER RESEARCH (2010)

Article Oncology

Galectin-3 in urine of cancer patients: stage and tissue specificity

Kiruthika Balasubramanian et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)

Review Immunology

Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation

Gabriel A. Rabinovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Review Biochemistry & Molecular Biology

Functions of cell surface galectin-glycoprotein lattices

Gabriel A. Rabinovich et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2007)

Article Multidisciplinary Sciences

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

Victor L. J. L. Thijssen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Medicine, Research & Experimental

Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration

Jiale He et al.

LABORATORY INVESTIGATION (2006)

Article Biochemical Research Methods

Comparative proteomic analysis of esophageal squamous cell carcinoma

YJ Qi et al.

PROTEOMICS (2005)

Article Biochemistry & Molecular Biology

Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity

G Elad-Sfadia et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Galectin-1 interacts with β-1 subunit of integrin

EP Moiseeva et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Article Biochemistry & Molecular Biology

Galectin-3 mediates the endocytosis of β-1 integrins by breast carcinoma cells

V Furtak et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)

Article Biochemistry & Molecular Biology

Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein

JW Park et al.

NUCLEIC ACIDS RESEARCH (2001)